FR2447191A1 - Preparation medicale contenant de la prostaglandine et son utilisation pour application intravaginale et intracervicale - Google Patents
Preparation medicale contenant de la prostaglandine et son utilisation pour application intravaginale et intracervicaleInfo
- Publication number
- FR2447191A1 FR2447191A1 FR8001797A FR8001797A FR2447191A1 FR 2447191 A1 FR2447191 A1 FR 2447191A1 FR 8001797 A FR8001797 A FR 8001797A FR 8001797 A FR8001797 A FR 8001797A FR 2447191 A1 FR2447191 A1 FR 2447191A1
- Authority
- FR
- France
- Prior art keywords
- intravaginal
- medical preparation
- preparation containing
- intracervical
- containing prostaglandin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003180 prostaglandins Chemical class 0.000 title abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- -1 HYDROXYL GROUPS Chemical group 0.000 abstract 1
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
LA PRESENTE INVENTION DECRIT UNE PREPARATION MEDICALE STABLE SOUS LA FORME DE PARTICULES ESSENTIELLEMENT SECHES, CONTENANT DE LA PROSTAGLANDINE ABSORBEE ETOU ADSORBEE DANS UN POLYMERE RETICULE RENFERMANT DES GROUPES HYDROXYLE, QUI EST INSOLUBLE DANS L'EAU, MAIS POSSEDE UNE APTITUDE AU GONFLEMENT DANS LES LIQUIDES CONTENANT DE L'EAU POUR FORMER UN GEL. UTILISATION DE CETTE PREPARATION POUR DES APPLICATIONS INTRAVAGINALES ETOU INTRACERVICALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7900737A SE431821B (sv) | 1979-01-29 | 1979-01-29 | Lagringsstabilt, prostaglandininnehallande medicinskt preparat |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2447191A1 true FR2447191A1 (fr) | 1980-08-22 |
FR2447191B1 FR2447191B1 (fr) | 1983-07-22 |
Family
ID=20337129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8001797A Granted FR2447191A1 (fr) | 1979-01-29 | 1980-01-28 | Preparation medicale contenant de la prostaglandine et son utilisation pour application intravaginale et intracervicale |
Country Status (10)
Country | Link |
---|---|
US (1) | US4352790A (fr) |
JP (1) | JPS55102512A (fr) |
BE (1) | BE881351A (fr) |
DE (1) | DE3001454A1 (fr) |
DK (2) | DK160739C (fr) |
FR (1) | FR2447191A1 (fr) |
GB (1) | GB2041220B (fr) |
NL (1) | NL190693C (fr) |
NO (1) | NO153520C (fr) |
SE (2) | SE431821B (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0116358A1 (fr) * | 1983-02-12 | 1984-08-22 | Bayer Ag | Complexes de prostaglandines |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2047093B (en) * | 1979-03-21 | 1983-12-07 | Graham N B | Controlled release compositions |
US5079009A (en) * | 1979-03-21 | 1992-01-07 | National Research Development Corporation | Controlled release compositions including polyethylene oxide with urethane cross-linking |
IT1131833B (it) * | 1980-06-20 | 1986-06-25 | Crinos Industria Farmaco | Eccipienti per sostanze spermicide |
ZA831186B (en) * | 1982-03-22 | 1983-11-30 | Upjohn Ltd | Gelled pge2/triacetin solutions |
AU546872B2 (en) * | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
DE3307816A1 (de) * | 1983-03-02 | 1984-09-06 | Schering AG, 1000 Berlin und 4709 Bergkamen | Prostaglandin-haltiges pharmazeutisches praeparat und seine herstellung |
GB8403360D0 (en) * | 1984-02-08 | 1984-03-14 | Erba Farmitalia | Pharmaceutical compositions |
DE3428264A1 (de) * | 1984-07-27 | 1986-03-06 | Schering Ag | Gelhaltige pharmazeutische zubereitungen |
IE59361B1 (en) * | 1986-01-24 | 1994-02-09 | Akzo Nv | Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension |
JP2590358B2 (ja) * | 1988-03-01 | 1997-03-12 | 正雄 五十嵐 | 子宮内膜症治療用の子宮内又は膣内投与製剤 |
JPH03220201A (ja) * | 1988-11-18 | 1991-09-27 | Eisai Co Ltd | プロスタグランジン類と多糖類の結合体 |
CH678697A5 (fr) * | 1989-04-03 | 1991-10-31 | Warner Lambert Co | |
EP0661052A1 (fr) * | 1991-11-08 | 1995-07-05 | Kyoto Pharmaceutical Industries, Ltd. | Preparation pharmaceutique contenant un compose de prostaglandine a administrer par voie rectale ou vaginale |
US6946442B2 (en) * | 1994-11-30 | 2005-09-20 | Asif Syed Ahmed | Method of hastening cervical ripening |
AU5794196A (en) * | 1995-06-01 | 1996-12-18 | G.D. Searle & Co. | Stabilized solid dispersions of misoprostol |
AU742787B2 (en) | 1997-07-09 | 2002-01-10 | Androsolutions, Inc. | Improved methods and compositions for treating male erectile dysfunction |
US6103765A (en) | 1997-07-09 | 2000-08-15 | Androsolutions, Inc. | Methods for treating male erectile dysfunction |
FR2766709B1 (fr) | 1997-07-31 | 2000-04-07 | Dominique Cingotti | Procede pour la preparation d'un extrait de principes actifs sous forme de microgranules a base de fibres alimentaires entierement solubles destines a differentes formes galeniques |
US5891915A (en) * | 1998-05-01 | 1999-04-06 | Wysor; Michael S. | Method for enhancing female sexual response and an ointment therefor |
US6031002A (en) * | 1998-05-01 | 2000-02-29 | Michael Ebert | Method for enhancing female sexual response and a composition therefor |
US20070191320A1 (en) * | 1998-12-10 | 2007-08-16 | Nexmed Holdings, Inc. | Methods of treatment for female sexual arousal disorder |
US6486207B2 (en) | 1998-12-10 | 2002-11-26 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
GR1004266B (el) * | 2001-04-30 | 2003-06-18 | Ηλιας Κ. Παπαδοπουλος | Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας |
US20050181030A1 (en) * | 2003-01-03 | 2005-08-18 | Mo Y. J. | Topical stabilized prostaglandin E compound dosage forms |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2210415A1 (fr) * | 1972-12-18 | 1974-07-12 | Ortho Pharma Corp | |
US3888975A (en) * | 1972-12-27 | 1975-06-10 | Alza Corp | Erodible intrauterine device |
US3948254A (en) * | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
GB1516348A (en) * | 1974-09-18 | 1978-07-05 | Pharma Soc Of Victoria | Injectable compositions |
FR2373279A1 (fr) * | 1976-12-13 | 1978-07-07 | Ici Ltd | Composition a base d'un copolymere sequence pour la liberation prolongee d'un agent doue d'activite biologique |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4036954A (en) | 1973-11-02 | 1977-07-19 | Yamanouchi Pharmaceutical Co., Ltd. | Stable prostaglandin E group-containing formulation |
AR205997A1 (es) | 1973-11-21 | 1976-06-23 | American Cyanamid Co | Resina de poliester normalmente solida biodegradable e hidrolizable |
CH616694A5 (en) * | 1974-06-27 | 1980-04-15 | Ciba Geigy Ag | Process for the preparation of crosslinked, water-insoluble, hydrophilic copolymers |
JPS5256148A (en) * | 1975-10-16 | 1977-05-09 | Agency Of Ind Science & Technol | Process for preparing active substances having improved |
GB1554783A (en) | 1976-01-05 | 1979-10-31 | Population Res Inc | Pharmaceutical compositions for use in the permanent sterilization of female animals |
DE2709804C2 (de) * | 1976-03-12 | 1986-03-13 | Ono Pharmaceutical Co. Ltd., Osaka | Prostaglandin-analoga, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen |
-
1979
- 1979-01-29 SE SE7900737A patent/SE431821B/sv not_active IP Right Cessation
- 1979-12-17 SE SE7910354A patent/SE442167B/sv not_active IP Right Cessation
-
1980
- 1980-01-14 GB GB8001176A patent/GB2041220B/en not_active Expired
- 1980-01-16 DE DE19803001454 patent/DE3001454A1/de active Granted
- 1980-01-16 US US06/112,563 patent/US4352790A/en not_active Expired - Lifetime
- 1980-01-18 JP JP519880A patent/JPS55102512A/ja active Granted
- 1980-01-23 NL NL8000426A patent/NL190693C/xx not_active IP Right Cessation
- 1980-01-25 BE BE0/199113A patent/BE881351A/fr not_active IP Right Cessation
- 1980-01-25 NO NO800186A patent/NO153520C/no unknown
- 1980-01-28 FR FR8001797A patent/FR2447191A1/fr active Granted
- 1980-01-28 DK DK033580A patent/DK160739C/da not_active IP Right Cessation
-
1986
- 1986-07-03 DK DK316186A patent/DK160740C/da not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3948254A (en) * | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
FR2210415A1 (fr) * | 1972-12-18 | 1974-07-12 | Ortho Pharma Corp | |
GB1446626A (en) * | 1972-12-18 | 1976-08-18 | Ortho Pharma Corp | Composition for sustained release of a medicament and method of using same |
US3888975A (en) * | 1972-12-27 | 1975-06-10 | Alza Corp | Erodible intrauterine device |
GB1516348A (en) * | 1974-09-18 | 1978-07-05 | Pharma Soc Of Victoria | Injectable compositions |
FR2373279A1 (fr) * | 1976-12-13 | 1978-07-07 | Ici Ltd | Composition a base d'un copolymere sequence pour la liberation prolongee d'un agent doue d'activite biologique |
Non-Patent Citations (1)
Title |
---|
CA1980 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0116358A1 (fr) * | 1983-02-12 | 1984-08-22 | Bayer Ag | Complexes de prostaglandines |
Also Published As
Publication number | Publication date |
---|---|
SE7910354L (sv) | 1980-07-30 |
NL190693C (nl) | 1994-07-01 |
DE3001454C2 (fr) | 1990-05-10 |
US4352790A (en) | 1982-10-05 |
JPS55102512A (en) | 1980-08-05 |
NO153520C (no) | 1986-04-09 |
DK33580A (da) | 1980-07-30 |
JPH0140013B2 (fr) | 1989-08-24 |
DK316186A (da) | 1986-07-03 |
DE3001454A1 (de) | 1980-08-07 |
NL190693B (nl) | 1994-02-01 |
NO153520B (no) | 1985-12-30 |
SE431821B (sv) | 1984-03-05 |
NL8000426A (nl) | 1980-07-31 |
SE7900737L (sv) | 1980-07-30 |
NO800186L (no) | 1980-07-30 |
BE881351A (fr) | 1980-05-16 |
GB2041220A (en) | 1980-09-10 |
GB2041220B (en) | 1983-07-27 |
DK160739B (da) | 1991-04-15 |
DK160740B (da) | 1991-04-15 |
SE442167B (sv) | 1985-12-09 |
DK160740C (da) | 1991-09-30 |
FR2447191B1 (fr) | 1983-07-22 |
DK316186D0 (da) | 1986-07-03 |
DK160739C (da) | 1991-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2447191A1 (fr) | Preparation medicale contenant de la prostaglandine et son utilisation pour application intravaginale et intracervicale | |
FR2436607A1 (fr) | Dispositif pour l'epuration du sang | |
FR2448347A1 (fr) | Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques | |
FR2450610A1 (fr) | Medicament a coller sur la muqueuse buccale ou nasale et liberant lentement la substance active qu'il contient | |
BE1002109A3 (fr) | Composition pharmaceutique a activite analgesique. | |
FR2305197A1 (fr) | Appareil pour l'administration de liquides au corps humain et au corps des animaux | |
FR2284294A1 (fr) | Appareil d'assistance pour le traitement d'urgences medicales rencontrees notamment dans l'exercice de la medecine | |
MY101845A (en) | Emulsion type hair cosmetic. | |
FR2442054A1 (fr) | Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant | |
BE875634A (fr) | Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate | |
CA2095728A1 (fr) | Composition liquide, comme vehicule formant un gel | |
BE900660A (fr) | Composition therapeutique pour le traitement des sequelles d'intoxication. | |
MC978A1 (fr) | Préparations solides, de forme stable pour la desodrisation de l'air, contenant une substance active volatile | |
FR2385403A1 (fr) | Nouvelles compositions diagnostiques radio-actives contenant de l'albumine et leur procede de preparation | |
BE900563A (fr) | Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue. | |
FR2407715A1 (fr) | Composition de preparation topique et procede pour sa preparation | |
BE888082A (fr) | Compositions cosmetiques ou pharmaceutiques sous forme d'emulsions stables du type huile-dans-l'eau | |
PT76314A (en) | Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them | |
BE878140A (fr) | Pompe pour liquides, en particulier de faible viscosite, tels que l'eau, les alcools, et autres | |
Menkin | Role of inflammation in carcinogenesis | |
FR2358159A1 (fr) | Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant | |
SE7906467L (sv) | Hypo-beta-lipoproteinemiskt dietikum, forfarande for framstellning derav och anvendning derav | |
DE3264331D1 (en) | Aqueous preparation and its use in the preparation of ceramic masses | |
FR2388828A1 (fr) | 5-iodo-5'-amino-2',5'-didesoxycytidine et medicament contenant cette substance ou un sel de celle-ci | |
FR2277591A1 (fr) | Composition pharmaceutique pour la prevention et le traitement de l'alcoolisme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse | ||
RC | Opposition against decision of lapse | ||
DA | Annulment of decision of lapse |